BRIACELL THERAPEUTICS CORP. Diluted Shares Outstanding (Weighted Average)
BRIACELL THERAPEUTICS CORP. (BCTX) reported Diluted Shares Outstanding (Weighted Average) of 7.25 million shares for the 3-month period ending 2026-04-30, per its 10-Q filed 2026-06-09.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-06-09
- BRIACELL THERAPEUTICS CORP. weighted average number of shares outstanding, diluted for the quarter ending 2026-04-30 was 7.25M shares, a 1843.48% increase year-over-year.
- BRIACELL THERAPEUTICS CORP. weighted average number of shares outstanding, diluted for the quarter ending 2026-01-31 was 2.80M shares, a 938.07% increase year-over-year.
- BRIACELL THERAPEUTICS CORP. weighted average number of shares outstanding, diluted for the quarter ending 2025-10-31 was 1.88M shares, a 960.72% increase year-over-year.
- BRIACELL THERAPEUTICS CORP. weighted average number of shares outstanding, diluted for the quarter ending 2025-07-31 was 877.54K shares.
- BRIACELL THERAPEUTICS CORP. weighted average number of shares outstanding, diluted for fiscal 2025 was 423.11K shares, a 285.70% increase from fiscal 2024.
- BRIACELL THERAPEUTICS CORP. weighted average number of shares outstanding, diluted for fiscal 2024 was 109.70K shares, a 99.30% decline from fiscal 2023.
- BRIACELL THERAPEUTICS CORP. weighted average number of shares outstanding, diluted for fiscal 2023 was 15.62M shares, a 0.81% increase from fiscal 2022.
- BRIACELL THERAPEUTICS CORP. weighted average number of shares outstanding, diluted for fiscal 2022 was 15.49M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | 7.25M shares 10-Q · filed 2026-06-09 | 5.03M shares derived: average of 2 quarters · filed 2026-06-09 | 3.94M shares 10-Q · filed 2026-06-09 | 3.20M shares derived: average of 4 quarters · filed 2026-06-09 | ||||
| 2026-01-31 | 2.80M shares 10-Q · filed 2026-03-10 | 2.34M shares 10-Q · filed 2026-03-10 | 1.85M shares derived: average of 3 quarters · filed 2026-03-10 | 1.48M shares derived: average of 4 quarters · filed 2026-06-09 | ||||
| 2025-10-31 | 1.88M shares 10-Q · filed 2025-12-11 | 1.38M shares derived: average of 2 quarters · filed 2025-12-11 | 1.04M shares derived: average of 3 quarters · filed 2026-06-09 | 851.12K shares derived: average of 4 quarters · filed 2026-06-09 | ||||
| 2025-07-31 | 877.54K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-16 | 625.30K shares derived: average of 2 quarters · filed 2026-06-09 | 506.85K shares derived: average of 3 quarters · filed 2026-06-09 | 423.11K shares 10-K · filed 2025-10-16 | ||||
| 2025-04-30 | 373.07K shares 10-Q · filed 2026-06-09 | 3.74M shares 10-Q · filed 2025-06-16 | 321.51K shares derived: average of 2 quarters · filed 2026-06-09 | 271.64K shares 10-Q · filed 2026-06-09 | 2.72M shares 10-Q · filed 2025-06-16 | -484.23K shares derived: average of 4 quarters · filed 2026-06-09 | ||
| 2025-01-31 | 269.96K shares 10-Q · filed 2026-03-10 | 2.70M shares 10-Q · filed 2025-03-12 | 222.50K shares 10-Q · filed 2026-03-10 | 2.22M shares 10-Q · filed 2025-03-12 | -770.00K shares derived: average of 3 quarters · filed 2026-03-10 | -311.13K shares derived: average of 4 quarters · filed 2026-03-10 | ||
| 2024-10-31 | 177.61K shares 10-Q · filed 2025-12-11 | 26.64M shares 10-Q · filed 2024-12-16 | -1.29M shares derived: average of 2 quarters · filed 2025-12-11 | -504.83K shares derived: average of 3 quarters · filed 2025-12-11 | -112.26K shares derived: average of 4 quarters · filed 2025-12-11 | |||
| 2024-07-31 | -2.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-10-16 | -846.05K shares derived: average of 2 quarters · filed 2025-10-16 | -208.88K shares derived: average of 3 quarters · filed 2025-10-16 | 109.70K shares 10-K · filed 2025-10-16 | 16.45M shares 10-K · filed 2024-10-29 | |||
| 2024-04-30 | 1.07M shares 10-Q · filed 2025-06-16 | 15.98M shares 10-Q · filed 2024-06-14 | 1.07M shares derived: average of 2 quarters · filed 2025-06-16 | 1.07M shares 10-Q · filed 2025-06-16 | 15.98M shares 10-Q · filed 2024-06-14 | 8.68M shares derived: average of 4 quarters · filed 2025-06-16 | ||
| 2024-01-31 | 1.07M shares 10-Q · filed 2025-03-12 | 15.98M shares 10-Q · filed 2024-03-18 | 1.07M shares 10-Q · filed 2025-03-12 | 15.98M shares 10-Q · filed 2024-03-18 | 11.22M shares derived: average of 3 quarters · filed 2025-03-12 | 12.30M shares derived: average of 4 quarters · filed 2025-03-12 | ||
| 2023-10-31 | 16.67M shares 10-Q · filed 2024-12-16 | 16.30M shares derived: average of 2 quarters · filed 2024-12-16 | 16.04M shares derived: average of 3 quarters · filed 2024-12-16 | 15.91M shares derived: average of 4 quarters · filed 2024-12-16 | ||||
| 2023-07-31 | 15.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-29 | 15.72M shares derived: average of 2 quarters · filed 2024-10-29 | 15.65M shares derived: average of 3 quarters · filed 2024-10-29 | 15.62M shares 10-K · filed 2024-10-29 | ||||
| 2023-04-30 | 15.52M shares 10-Q · filed 2024-06-14 | 15.52M shares derived: average of 2 quarters · filed 2024-06-14 | 15.52M shares 10-Q · filed 2024-06-14 | 15.52M shares derived: average of 4 quarters · filed 2024-06-14 | ||||
| 2023-01-31 | 15.52M shares 10-Q · filed 2024-03-18 | 15.52M shares 10-Q · filed 2024-03-18 | 15.52M shares derived: average of 3 quarters · filed 2024-03-18 | 15.48M shares derived: average of 4 quarters · filed 2024-03-18 | ||||
| 2022-10-31 | 15.52M shares 10-Q · filed 2023-12-14 | 15.52M shares derived: average of 2 quarters · filed 2023-12-14 | 15.47M shares derived: average of 3 quarters · filed 2023-12-14 | 16.20M shares derived: average of 4 quarters · filed 2023-12-14 | ||||
| 2022-07-31 | 15.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-25 | 15.44M shares derived: average of 2 quarters · filed 2023-10-25 | 16.43M shares derived: average of 3 quarters · filed 2023-10-25 | 15.49M shares 10-K · filed 2023-10-25 | ||||
| 2022-04-30 | 15.36M shares 10-Q · filed 2023-06-14 | 16.88M shares derived: average of 2 quarters · filed 2023-06-14 | 15.49M shares 10-Q · filed 2023-06-14 | |||||
| 2022-01-31 | 18.41M shares 10-Q · filed 2023-03-16 | 15.55M shares 10-Q · filed 2023-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |